Dr. Alan Kivitz to Chair XBiotech’s Natrunix Program in Rheumatoid Arthritis
is now Lead Investigator & Study Chairman for its clinical research program for Natrunix in Rheumatoid Arthritis.
- is now Lead Investigator & Study Chairman for its clinical research program for Natrunix in Rheumatoid Arthritis.
- The company has now enrolled about 33% of the 210 patients it is recruiting for a Phase II, Double-Blind, Placebo-Controlled, Randomized study, examining Natrunix in combination with methotrexate for the treatment of Rheumatoid Arthritis.
- I am excited to be part of a clinical trial program studying a novel approach to RA.”
Dr. Kivitz has had a prodigious medical career treating arthritis and rheumatic diseases. - Dr. Kivitz has authored over 500 research articles, abstracts, and clinical studies relating to osteoarthritis, osteoporosis and rheumatoid arthritis and has lectured on his findings around the world.